Comparative effects of SGLT2 inhibitors, pioglitazone, DPP-4 inhibitors, and sulfonylureas on dementia risk in type 2 diabetes. // The Journal of Prevention of Alzheimer's Disease. – URL: https://www.sciencedirect.com/science/article/pii/S2274580726002141?dgcid=rss_sd_all
Comparative effects of SGLT2 inhibitors, pioglitazone, DPP-4 inhibitors, and sulfonylureas on dementia risk in type 2 diabetes. The Journal of Prevention of Alzheimer's Disease. https://www.sciencedirect.com/science/article/pii/S2274580726002141?dgcid=rss_sd_all
“Comparative effects of SGLT2 inhibitors, pioglitazone, DPP-4 inhibitors, and sulfonylureas on dementia risk in type 2 diabetes.” The Journal of Prevention of Alzheimer's Disease.
@article{article68181,
title = {Comparative effects of SGLT2 inhibitors, pioglitazone, DPP-4 inhibitors, and sulfonylureas on dementia risk in type 2 diabetes},
journal = {The Journal of Prevention of Alzheimer's Disease},
url = {https://www.sciencedirect.com/science/article/pii/S2274580726002141?dgcid=rss_sd_all}
}